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Technical University of Denmark, Kongens Lyngby, DenmarkABSTRACT After infection of a sensitive host temperate phages may enter either a lytic or a lysogenic pathway leading to new
phage assembly or silencing as a prophage, respectively. The decision about which pathway to enter is centered in the genetic
switch of the phage. In this work, we explore the bistable genetic switch of bacteriophage TP901-1 through experiments and
statistical mechanical modeling. We examine the activity of the lysogenic promoter PR at different concentrations of the phage
repressor, CI, and compare the effect of CI on PR in the presence or absence of the phage-encoded MOR protein expressed
from the lytic promoter PL. We find that the presence of large amounts of MOR prevents repression of the PR promoter, verifying
that MOR works as an antirepressor. We compare our experimental data with simulations based on previous mathematical
formulations of this switch. Good agreement between data and simulations verify the model of CI repression of PR. By including
MOR in the simulations, we are able to discard a model that assumes that CI and MOR do not interact before binding together at
the DNA to repress PR. The second model of PR repression assumes the formation of a CI:MOR complex in the cytoplasm. We
suggest that a CI:MOR complex may exist in different forms that either prevent or invoke PR repression, introducing a new twist
on mixed feedback systems.INTRODUCTIONEpigenetic differentiation is found in a wide range of bio-
logical areas. Perhaps most appreciable is the differentiation
of human cells, which carry the same genetic material but
present truly different phenotypes. Sustained differentiation
relies on the existence of multiple stable states. Bistability is
the simplest example of this multistability, and is readily
seen in investigations of the reciprocal transcription repres-
sion exemplified by the genetic switch of Escherichia coli
phage l (Fig. 1 A) (1). However, bistability may be acquired
by motif designs that are quite different from the classical
motif as shown in in silico studies (2,3). One of these is
the mixed feedback loop (MFL), in which protein A regu-
lates the expression of protein B and the less-abundant
protein is sequestered into an inactive heteromer with the
other protein (Fig. 1 B). Such sequestration combined with
repression invoked by the heteromer has been proposed to
be part of the genetic switch mechanisms of the temperate
Lactococcal phage TP901-1 (Fig. 1, C and D) (4,5). In
line with earlier work, we define the immune state of this
genetic switch as when the early lytic promoter PL is
repressed, and accordingly call the state of an open PL
promoter the antiimmune state (Fig. 1, E and F). In the
immune state, the phage-encoded repressor, CI, represses
transcription from PL through cooperative binding at the
operator sites OR and OL (6). Further cooperative binding
of CI to a distant operator site OD tightens this repression
(4). CI binding at OR also represses the early lysogenic
promoter PR, though only partly, because OR is a relatively
weak CI-binding site. The binding sequences for CI and theSubmitted August 24, 2010, and accepted for publicationDecember 2, 2010.
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0006-3495/11/01/0313/9 $2.00affinities of CI to the DNA were determined by Johansen
et al. (6), who reported binding affinities of CI to OL and
OR of 28 nM and >2000 nM, respectively. Since the
sequence of the OD site is similar to the consensus CI-oper-
ator site and since preliminary gel mobility shift assays have
shown that CI binds with the same affinity to OD as to OL
(M. Pedersen, unpublished data) the binding constant of
CI at OD is considered as equal to CI binding at OL (6).
MOR is known to function as an antirepressor, and tight
repression of PR in the antiimmune state is only obtained
in the presence of both CI and the phage-encoded protein
MOR, and is apparently independent of the known CI oper-
ator sites (7,4). In vivo studies have shown that MOR alone
does not repress any of the two promoters (4). Furthermore,
gel mobility shift assays using DNA fragments covering the
region from þ70 for the PR promoter to þ140 for the PL
promoter and purified MOR protein did not reveal any inter-
action of MOR with DNA in vitro (data not shown).
The tight repression of PR in the antiimmune state
involves CI, MOR, and supposedly the DNA in the vicinity
of the PR promoter, but this interaction has not been verified
experimentally (8). However, all temperate phages that
encode MOR homologs also hold a conserved region in
CI. This conserved region was proposed to be important
for the CI-MOR interaction (9). A previous in silico study
confirmed that interactions among CI, MOR, and DNA
could play a role in the repression of PR. However, it was
not possible to determine exclusively whether the CI:MOR
complex should form directly on the DNA or act partly
through sequestration before DNA binding (5).
In this work we consider two genetic systems based on the
minimal switch fragment isolated by Pedersen and Hammer
(4) with CI introduced in trans from a synthetic promoterdoi: 10.1016/j.bpj.2010.12.3681
TABLE 1 Parameters andmain equations of the mathematical
models
Dimerization and heteromerization
CIþ CI5CI2;
½CI2
½CI2 ¼ Kdim ¼ expðDGdim=kBTÞ
CIþMOR5CI:MOR;
½CI½MOR
½CI:MOR ¼ Khet ¼ expðDGhet=kBTÞ
Total protein concentration
½CItotal ¼ ½CIfree þ 2 ½CI2 þ ½CI:MOR
½MORtotal ¼ ½MORfree þ ½CI:MOR
½MORtotal ¼ ½MORfree þ ½CI:MOR
Sum of free energies of species in Fig. 4 C
DGs Species i(s)* j(s)*
0 A 0 0
DGdim þ DGL B1 2 0
DGdim þ DGR B2 2 0
DGdim þ DGD B3 2 0
2 DGdim þ DGR þ DGL þ DGpair C 4 0
2 DGdim þ DGR þ DGD þ DGpair D 4 0
2 DGdim þ DGL þ DGD þ DGpair E 4 0
3 DGdim þ DGR þ DGL þ DGD þ DGpair F1–3 6 0
3 DGdim þ DGR þ DGL þ DGD þ DGtriplet G 6 0
Species weight*
fs ¼ ½MOR
jðsÞ½CIiðsÞexpðDGs=kBTÞ
P
sð½MORjðsÞ½CIiðsÞexpðDGs=kBTÞÞ
Promoter activityy
pRð½CI; ½MORÞ ¼ pR0
P
s0
fs
pLð½CIÞ ¼ pL0
P
s0
fsh½MORtotal
*i(s) and j(s) refer to the number of bound CI and MOR, respectively.
ys0 refers to the binding species that allows activity from the respective
promoter.
FIGURE 1 Top: Schematic representation of three motifs that may serve
as a bistable switch. Arrow represents activation of transcription, blunt
arrows (x) represent repression. (A) The classical bistable motif of recip-
rocal transcription repression as found in phage l. (B) The MFL. Protein A
may regulate expression of B through repression or activation. The seques-
tration of A into the heteromer allows for a stable state with high levels of B,
where all of A is captured in the A:B complex. (C) Speculated motif of the
TP901-1 switch. In addition to sequestration of A, the heteromer functions
as a repressor of A. (D) The elements of the genetic switch fragment of
phage TP901-1, including the two promoters (PR and PL), the two promoter
proximal genes (cI andmor), the three known CI operator sites (OR, OL, and
OD), and the speculated CI:MOR operator site (OM). The CI repression of
PL and autoregulation of PR, and the proposed adjoined CI andMOR repres-
sion of PR, are indicated by thex symbol. (E and F) The proposed under-
lying mechanisms of the immune and antiimmune states of the TP901-1
switch adopted from Pedersen and Hammer (4).
314 Alsing et al.library (10,11). We find that the presence of MOR allows PR
to be active at CI concentrations where PR is otherwise
repressed byCI, and deduce that ifMORworks through inter-
action with CI in a heteromer protein complex, this complex
must form in the cell cytoplasm before binding at the DNA.
Finally, we combine our biological results with mathematical
modeling. For the immune state, we probe different levels of
involved cooperativity in the binding of CI dimers at the known
operator sites. The model predicts the relative weakness of CI
binding at the OR site seen experimentally. For the antiimmune
state, the model verifies the need for CI:MOR complex forma-
tion. However, the biological data obtained in this study can be
explained without direct repression of PR by the CI:MOR
complex, indicating that the biological model of the underlying
mechanisms should be revised.
THEORY
The models used for analysis are based on the grand canon-
ical approach of Ackers et al. (12) and Shea and Ackers
(13). They are extended versions of the models presentedBiophysical Journal 100(2) 313–321for a simplified TP901-1 switch by Nakanishi et al. (5),
and include CI binding at all known CI-binding sites and
levels of cooperativity.
An elaborate description of the models is given in the Sup-
porting Material, and the main equations are replicated in
Table 1. Briefly, the activity probability of each promoter is
represented as a function of the concentration of free CI.
For each model, all possible binding conformations between
CI and its operator sites are listed. Each of these binding
species is assigned a statistical weight that is normalized
such that the species of all free operator sites is given aweight
of one. The promoter activity probability is the sum of
weights of binding species that allow promoter activity (see
Table S1). The total concentration of CI and MOR is ex-
pressed as the sumof components using equilibrium kinetics.
We based our investigation of the cooperativity in CI
binding on the general assumptions that CI binds as a dimer,
and that binding of CI at OR blocks activity of both PR and
PL, whereas CI binding at OL only blocks activity from PL. It
is assumed that CI binding at OD alone does not influence
the promoter activities.
A survey of models of increasing cooperativity between
bound CI dimers led us to a model that assigns individual
Modeling the Phage TP901-1 Switch 315energies to pair- and triplewise cooperative binding. The
model ignores the energy associated with the DNA loop
of OR-OD or OL-OD cooperative binding, and was chosen
to keep the number of model parameters limited. It is justi-
fied because, to date, no experimental determinations of
binding energies allow us to make distinctions between
pairwise cooperativity with or without loop formation.
The 14 species included in the model are listed in Table S1.
To include MOR in the repression of PR, we focused on
two main models (5): model A, in which the CI:MOR
complex associates at the DNA, and model B, in which
the CI:MOR complex forms before binding at the DNA.
In both models, it is assumed that a complex that is bound
at a putative OM site prevents activity from the PR promoter
without disturbing the activity from PL. This should be
consistent with the experimental indications that MOR
abolishes CI repression of PL while inflicting a tighter
repression of PR in concert with CI (4). In addition, we
assume that complex binding does not hinder CI dimer
binding at its known operator sites and vice versa. Including
MOR in the model thus effectively doubles the number of
states to 28.MATERIALS AND METHODS
Bacterial strains, transformation, and growth
conditions
Table 2 lists the bacterial strains used in this work. E. coli was propagated
in Luria-Bertani medium at 37C with agitation (14). In solid medium,
1.5% (wt/Vol) Bacto agar was used. When appropriate, the medium was
supplemented with Ampicillin (100 mg/mL) or Tetracycline (4 mg/mL).
Plasmid DNA was introduced into E. coli by electroporation as described
previously (8). Lactococcus lactis subsp. cremoris MG1363 was grown
at 30C in GM17 medium (M17 broth supplied with 0.5% glucose) con-
taining Erythromycin (5 mg/mL), Chloramphenicol (5 mg/mL), or Tetracy-
cline (2 mg/mL) when appropriate. Lactococcal cells were made
electrocompetent and transformed by electroporation as previously
described (15). Screening on 5-bromo-4-chloro-3-indolyl-b-D-galactopyr-
anoside (X-gal) plates was performed at an X-gal concentration of
90 mg/mL.DNA techniques
Plasmid isolation from E. coli was done using Qiaprep Spin Miniprep Kit
250 (Qiagen, Duesseldorf, Germany). Conventional restriction enzymes
and T4 DNA ligase were obtained from Fermentas Life Sciences
(St. Leon-Rot, Germany) and used according to protocol. A GFX PCR Il-
lustra DNA and GelBand Purification Kit (GE Healthcare, Broendby,
Denmark) was used for purification of DNA fragments. PCR amplifications
were performed for verification of inserts and products intended for cloning
with Taq or ExTaq polymerase, respectively. Both polymerases and buffers
were acquired from New England BioLabs (Ipswich, MA) and used as
described by the supplier.Construction of plasmids and strains
The plasmids and primers used in this study are listed in Table 2. Plasmid
pAKA5 was constructed in E. coli by ligation of a purified 0.8 kb HindIII-PstI fragment obtained from plasmid pPV40 (provided by P. Varmanen,
Faculty of Veterinary Medicine, University of Helsinki) and a purified
6.6 kb fragment obtained by digestion of pCS574 (16) with HindIII and
PstI. The orientation of pepI was verified by sequencing.
Plasmid pMAP86 was constructed as follows: A DNA fragment contain-
ing cI1OR þOLþmor1ODþ was constructed by ligation of two XbaI digested
DNA fragments obtained by PCR amplification using plasmid pMAP53
(cIþ OR þOL þmor 1ODþ) (4) as template DNA and primers CImut.for
with pAK80erm and primer CImut.rev with pAK80, respectively. The
primers introduced a XbaI restriction site and a frame-shift mutation at
the beginning of cI, similar to the cI mutation (cI1) introduced in
pPM131 (7). The DNA fragment was cloned using the TOPO TA cloning
kit from Invitrogen (San Diego, CA). The insert was transferred as aHindIII
fragment to the promoter probe plasmid pAK80, and the orientation of the
insert was verified by sequencing.
Strain LB436 (17) was transformed with plasmid pMAP86(mor1, cI1,
PR-lacLM), pMAP88(morþ,cI1, PR-lacLM), or pMAP87(morþ,cI1,
PL-lacLM) (4) to construct strain LAKA2, LAKA8, or LAKA9, respec-
tively. Strains SPLAKA1, SPLAKA3, and SPLAKA4, which contain
synthetic promoter libraries (PSP) of cI-pepI, were constructed using the
Solem-Jensen approach (11). PCR products containing cI transcribed by
synthetic promoters were constructed using pMAP50 (8) as template,
primer cIPst.rev, and one of the synthetic promoter primers. Upon digestion
of the PCR products and plasmid pAKA5 by PstI and XbaI, a ligation
mixture of the two was introduced into each of the three strains (LAKA2,
LAKA8, and LAKA9). Transformants were chosen based on a decrease
in the blue color of the colonies when grown on X-Gal-supplemented
agar as compared with the parent strains. Integration of a synthetic
promoter cI fragment upstream of the pepI reporter gene on the chromo-
some was subsequently verified by altered PepI activity compared with
strains transformed with pAKA5 containing the promoter less pepI.Enzyme activity assays
Cell extracts for the enzyme assays were prepared in the following way:
L. lactis cells were grown in 100 mL GM17 medium with appropriate anti-
biotics at 30C to an optical density of OD600 ¼ 0.5. Then 90 mL of each
sample were harvested, washed once in 4 mL 50 mM HEPES buffer pH 7,
and resuspended in 980 mL of the same buffer, all performed on ice. The
samples were subsequently stored in suitable volumes at 80C. On the
day of the assay, the samples were thawed on ice and the cells were ruptured
using a FastPrep bead beater. Cell debris and FastPrep beads were removed
by centrifugation and the resulting supernatant was used as the protein
extract in the assays.
PeptidaseI activity assays were performed in a manner similar to that
described by Varmanen et al. (18) on 1.5–8 mg total protein, in 50 mM
HEPES buffer, pH 7, using 10 mL L-Proline-para-nitroanilide (100 mM)
as substrate in a final assay volume of 1 mL. The release of nitroanilide
was followed at 410 nm (Zeiss thermostatic spectrophotometer, Zeiss,
Jena, Germany) at 37C.
The b-galactosidase activity was assayed as described previously (19)
with some modifications. Assays were performed at 30C on 0.3–4 mg total
protein diluted in Z-buffer to a total volume of 650 mL. After the samples
were preheated, the assay was initiated by addition of 100 mL Ortho-Nitro-
phenyl-b-galactoside (4 mg/mL) and stopped by addition of 250 mL of
Na2CO3 when the sample had turned slightly yellow, resulting in a final
assay volume of 1 mL. The release of orthonitrophenol was subsequently
determined as the change in optical density at 422 nm between the assay
sample and a similar sample in which no reaction of b-Galactosidase had
been allowed.
Using the molar extinction coefficients of 8800 M1cm1 and
4500 M1cm1 for nitroanilide at 410 nm (19) and orthonitrophenol at
422 nm (18), respectively, the specific enzyme activity was calculated in
units of nanomole substrate processed per minute per milliliter of cell
extract per 280 nm optical density.Biophysical Journal 100(2) 313–321
TABLE 2 Bacterial strains, plasmids, and primers used in this study
Strain, plasmid, or primer Description or sequencez (50-30) Reference or construct
Strains
L. lactis subsp. cremoris
MG1363 Plasmid-free derivative of NCDOO712 (28)
LB436 MG1363/pLB65 (17)
MP401 MG1363/pMAP50 (8)
LAKA2 LB436/pMAP86 This study
LAKA8 LB436/pMAP88 This study
LAKA9 LB436/pMAP87 This study
SPLAKA1 LAKA2/pAKA5::PSP* -cI-pepI integrated in attB This study
SPLAKA3 LAKA8/pAKA5::PSP* -cI-pepI integrated in attB This study
SPLAKA4 LAKA9/pAKA5::PSP* -cI-pepI integrated in attB This study
E. coli
DH5a ø80lacZ D(lacZYA-arg F)U169 rec A1 Stratagene
Plasmids
pLB65 pCI372::1.9-kb Eco RI-Sal I pLB61 orf 1TP901–1, oriE.coli, Cam
R (17)
pPV40 pLB85 DgusA::pepI, ErmR, oriE.coli
y
pAK80 Promoter probe vector containing lacLM, ErmR (29)
pMAP50 pAK80::cIþ morþ PL -lacLM, oriL.lactis, ErmR (8)
pMAP53 pAK80::cI þmor 1 PR -lacLM, oriL.lactis, Erm
R (4)
pMAP86 pAK80::cI 1 mor 1 PR -lacLM, oriL.lactis, Erm
R This study
pMAP87 pAK80::cI 1 morþ PL -lacLM, oriL.lactis, Erm
R (4)
pMAP88 pAK80::cI 1 morþPR -lacLM, oriL.lactis, Erm
R (4)
pCS574 pLB85 derivative, gusA, attPTP901-1, oriE.coli, Bla
R, TetR (16)
pAKA5 pCS574 DgusA::pepI, attPTP901-1, Tet
R This study
Primersz
cIPst.rev GGGGGGCTGC AG TCATAAATC GCCTTTATCA A CI library
promcI GGGGGGTCTA GAAAGCTT NN NNNAGTTTAT TCTTGACANN CI library
NNNNNNNNNN NNTGRTATAATNNNNTTATA CAAAATAAAA
AAGAGGTTTT TAT
prAKA1.sp GGGGGGTCTA GAAAGCTT GG GNNNNNTATT CTTGAACNNN CI library
NNNNNNNNNN NCGCTANAAT NNNNTTATAC AAAATAAAAA
AGAGGTTTTT ATG
prAKA4.sp GGGGGGTCTA GAAAGCTT GG GNNNNNATTT TTTTGTTGAA CI library
CNNNNNNNNN NNNNNCGCTA NAATNNNNTT ATACAAAATA
AAAAAGAGGT TTTTATG
CImut.for GAAAACTGAT TCTAGATAGT AATAGGC pMAP86
pAK80erm CTTTCAACTG CCTGGCAC pMAP86
CImut.rev GCCTATTACT ATCTAGA ATC AGTTTTC pMAP86
pAK80 TCCTTTCAAA GTTACCCTAATC pMAP86
*Library of synthetic promoters.
ySupplied by P. Varmanen.
zEnzyme restriction sites are underlined. N is any of the four bases, and R is 50% A and 50% G.
316 Alsing et al.Western blotting
The protein concentration was determined by measuring OD280 (1 OD280¼
1 mg/mL). Generally, samples containing 200 mg protein were prepared for
analysis by sodium dodecyl sulfate polyacrylamide gel electrophoresis
using 15% gels. After separation, the proteins were transferred onto Hy-
bond P (PVDF) membranes (GE Healthcare Life Sciences) by electroblot-
ting with a semidry blotter (BioRad, Hercules, CA). Western blotting was
performed as described previously (4).Fitting models to data
We quantified the goodness of fit between the models and data by calcu-
lating an unweighted sum of squared residues (SSR); 106 parameter sets
were tested in each fitting procedure. Parameters were randomly chosen
such that the basal activity of the PR promoter, pR0, lay between LacLM
activities of 23 and 30, in similarity to the basal level in the data sets.Biophysical Journal 100(2) 313–321The six energy parameters were taken between 15 and 0 kcal/mol corre-
sponding to binding constants between 1011 and 101 M. In the presence
of MOR, we fixed the parameter sets found in the model describing MOR-
independent repression of PR and scanned the two additional binding
energies.
The CI concentration in cells containing the wild-type switch in the
immune state was estimated to 106 M corresponding to 1 wild-type
immune-state unit (WIU). This is based on a preliminary rough estimate
of TP901-1 CI concentration in vivo and is comparable to previous esti-
mates based on lysogenic CI concentrations in phage l (5). In the simula-
tions that did not include MOR, the estimated relation between WIU and
concentration set a reference for all of the binding energies. Changing
this relation would rescale all binding energies proportionally without
changing any other results. The concentration of MOR is upheld by the
stronger promoter PL, which is initially open when CI is introduced into
the systems. We thus set the concentration of MOR in the antiimmune state,
where PL is active, to 10 times the concentration of CI in the immune state
of the system.
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PR is repressed 25-fold by a 600-fold increase in CI
A 979 bp DNA fragment containing the divergently oriented
early promoters (PR andPL), the three knownCIoperator sites,
and the genesmor and cI (both of which are required for bist-
ability) was isolated from the genome of phage TP901-1 and
shown to be bistable when cloned in a low-copy-number
plasmid and introduced in a compatible host (8).
To measure the activity of the PR promoter at different CI
concentrations in the absence of MOR, we used plasmid
pMAP86, which holds the genetic switch fragment with
frame-shift mutations in cI and mor and a LacLM reporter
gene downstream of the PR promoter (Fig. 2 A, left). The
bare activity of PR in the absence of any CI protein was
measured as 30 5 7 nmol processed Ortho-Nitrophenol-
b-galactoside per minute per milliliter of cell extract per
OD280. We then introduced CI in trans using a library ofFIGURE 2 Effect of constitutive CI expression on PR activity in the
absence (A) or presence (B) of a functional mor gene, and PL activity in
the presence of mor (C). Drawings to the left illustrate the components of
the reporter system. Genes with a frame-shift mutation are shown in white.
Inverted gray arrows and white box indicate operator sites as in Fig. 1.
LacLM and PepI activities are measured in nanomoles of processed
Ortho-Nitrophenol-b-galactoside or L-proline-para-nitroanilide, respec-
tively, per minute per milliliter of cell extract per OD280. Each data point
corresponds to a different synthetic promoter and is an average of at least
two independent activity measurements. Error bars are standard deviations
of the mean of LacLM activity. Insets in A and B show close-ups of PepI
activity region 1–100 (note the different ordinate values).synthetic constitutive promoters integrated on the bacterial
chromosome (11,20). To monitor the level of CI, we placed
the reporter gene pepI downstream of cI. Each strain thus al-
lowed us to determine the PR activity reported by LacLM at
a constitutive level of CI reported by PepI. The promoter
activity given by the LacLM activity is plotted against the
CI expression determined by the PepI activity in Fig. 2 A.
We observe a 25-fold decrease in PR activity over an
~600-fold change in CI expression. The decrease in activity
apparently contains a plateau stretching over a 10-fold
increase in CI concentration where the PR activity is held
at approximately half of its full activity.MOR acts as an antirepressor of PR
To measure the activity of PR in the presence of MOR at
various CI concentrations, we constructed a number of
strains that contained plasmid pMAP88 holding a frame-
shift mutation only in cI and with PR activity reported by
lacLM (8). Again CI was introduced from a single copy
on the chromosome and monitored by the reporter PepI
(Fig. 2 B, left).
The resulting data points of LacLM activity (PR activity)
versus PepI activity (CI concentration) are shown in
Fig. 2 B. PR is repressed ~500-fold as CI concentration
increases 600-fold, but the repression is not observed until
the last 10-fold increase in CI expression occurs. Thus,
the presence of MOR renders the PR promoter open, even
at the CI concentration at which the promoter was partially
repressed in the absence of MOR (Fig. 2, A and B).
In addition to the studies on PR promoter activity, we per-
formed a smaller sampling to examine the response of the PL
promoter to different levels of CI in the presence of MOR.
Plotting the PL activity (LacLM activity) against the CI
expression (PepI Activity) confirms that mor is indeed tran-
scribed in the strains for CI expression beyond levels at
which the PR promoter is closed (Fig. 2 C, and insets in A
and B).
To verify a linear correlation between the PepI activity
level and CI concentration in our systems, we performed
Western blotting on a selection of the assay samples
(Fig. 3). The plot shows the PepI activity versus CI concen-
tration in units of the CI concentration in a system contain-
ing a wild-type switch in the immune state (i.e., the WIU).
The linear relation is clear from the least-square fit and
was used to rescale the experimental PepI activity units to
CI concentrations before model fitting was conducted.Models predict the relative weakness
of CI binding at OR
To investigate the CI-invoked PR repression, we used the
model presented in Table 1 to fit the data set on PR response
to increasing CI concentrations (Fig. 2 A). For each param-
eter set, we calculated an unweighted SSR.Biophysical Journal 100(2) 313–321
FIGURE 3 Relation between CI concentration
and PepI activity. Left: Western blots correspond-
ing to the points in the right-hand plot. CI concen-
tration was determined in units of the CI level
found in cells containing plasmid pMAP50
carrying the wild-type switch in the immune state
corresponding to 1 WIU (lanes marked Immune
State). Specific PepI activity is given in nanomoles
of processed L-proline-para-nitroanilide per
minute per milliliter of cell extract per OD280.
The linear least-square fit follows [CI]total ¼
0.66  (PepI activity) with R2 ¼ 0.99. Note the
logarithmic axes.
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OR include both dimerization and DNA binding (6).
However, they relate the binding energy parameters that
describe CI dimer binding to OR and OL. Hence, we initially
restricted the parameters such thatDGR ~DGLþ ln(2000/28)
kBT. Additionally,DGL ~DGD due to the conserved sequence
of OD to the consensus sequence of OL (6). The best fit found
with these constraints on the model parameters is plotted
togetherwith the experimental data in Fig. 4A (dashed curve,
SSR ~ 130).
An additional fitting procedure was set up without any
constraints on the relations between parameters. From this
fit, all simulations of SSR< 100 reproduced the plateau indi-
cated in the data and were subjected to further investigation.
The best-fitting PR repression curve generated by the uncon-
strained fitting is plotted in Fig. 4 A (solid line, SSR ~ 60).
Both of the simulations presented in Fig. 4 A show an
acceptable fit to the data. The hypothetical thermodynam-
ical parameters predicted by the simulations are linked to
the lysogenic CI level, which we assume to be 106 M.
This concentration would be matched by a CI-binding
energy of order ~kBT ln 10
-6~ 8 kcal/mol. Binding ener-
gies that are weaker than this (DG > 8 kcal/mol) imply
that the corresponding binding rarely occurs at standard
lysogenic concentrations.
In our unconstrained simulation, the obtained CI dimer-
ization energy is DGDIM ¼ 3.6 kcal/mol, implying that
there are almost no free dimers in a lysogen. Thus, dimers
only form on the DNA. The obtained weak dimerization
therefore reflects a cooperative effect associated with CI
dimerization on the operators.
Our constrained simulation represents the opposite
scenario, where the CI dimerization is so strong that CI
instantly forms dimers. In this case, DGR (and DGDIM) of
the simulation may be related to the measured dissociation
constant for CI on OR, KR ¼ 2*exp(DGR/kBT) ~ 2600 nM
(where the factor 2 is associated with the strong dimeriza-
tion limit; for further details, see Supporting Material). In
the constrained simulation, the cooperativity is reflected
in weaker CI dimer binding to single operators aided byBiophysical Journal 100(2) 313–321DGPAIR ~ 3 kcal/mol (compare DGL, DGD between uncon-
strained and constrained parameters in Fig. 4, D and E).
In the remainder of this text, we focus on the results of the
unconstrained simulations because they provide some
predictions that validate the model. All of the implications
of the model when MOR is included later are similar for
the two simulations (see Fig. S2 and Fig. S3).
From the unconstrained fitting, all parameter sets sub-
jected to further investigation show the same pattern of
binding species. Eleven of the 14 binding species in the
model (Fig. 4 B) constitute the repression of PR and invoke
their individual effects over three intervals. At low CI
concentrations, the promoter is open because the species
of no bound CI dominates. With increasing concentration,
the species of two cooperatively bound CI dimers at
OR-OL or OR-OD dominate together with the species of
two dimers cooperatively bound at OL-OD (species C, D,
and E in Fig. 4 C). Together, these binding species constitute
the approximately half-repressed level of PR because only
species E allows activity from PR. At high CI concentra-
tions, all of the operator sites are covered by bound CI
dimers in either pair- or triplewise cooperative bindings, re-
sulting in full repression of PR.
Whether species C or D will balance species E depends on
the relation between the probabilities of the three states. This
relation is effectively given by the assigned binding strengths
of the three sites (OR, OL, and OD). We find that the two CI
operator sites assigned the weakest bindings are always
similar in binding energy, and OR is always found to be one
of the weaker sites. Thus, even without restricting the CI
dissociation constants toORandOL, themodel predicts a rela-
tive weakness of CI binding to the OR site.Simulations discard the model of direct binding
of CI and MOR at DNA
Initially, we simulated the repression of PR in the antiim-
mune state by direct binding of CI and MOR at a speculated
operator site, OM. This model does not allow CI and MOR to
interact before DNA binding occurs. We find that such
FIGURE 4 Model of PR repression by CI. (A) Simulation of PR activity
(constrained simulation in dashed line, unconstrained simulation in solid
line) as a function of total CI concentration together with experimental
data (solid circles). Repressor concentration is rescaled to units of immune
state CI level (WIU) according to Fig. 3. (B) Species fractions constituting
the PR repression curve of the unconstrained simulation in A as a function of
total CI concentration. Species represented by dashed curves allow activity
from PR, whereas the binding species indicated by black curves exclude
promoter activity. The gray line indicates the PR activity probability.
Species F1–3 are assigned the same total free energy in the model and
thus have identical species fraction curves (summed here for clarity). Refer
to Fig. S1 for a species fraction plot for the constrained fit. (C) Illustrations
of the binding species corresponding to the curves in B. Each black figure
represents a CI dimer. (D) Parameters of the constrained simulation:
[CI]total ¼ 106 M at full PR activity. The 50/50 plateau in the PR repression
is a result of a balance between the weights of species C and E. For other
parameter sets, species D takes the place of species C in the balance. In
a similar way, species G and F1–3 may contribute together or solely at
high CI total concentrations to invoke the full repression of PR. Species
B1–3 may contribute at low CI concentrations for other sets of parameters.
(E) Parameters of the unconstrained simulation: [CI]total ¼ 106 M at full
PR activity.
Modeling the Phage TP901-1 Switch 319a model cannot concurrently fit the two data sets in Fig. 2, A
and B. The dashed gray curve in Fig. 5 A shows the best fit of
this model to the experimental data. For all CI concentra-
tions, the curve falls at or below the PR activity curve pre-
dicted by the model of PR repression by CI dimers alone
(solid gray line). (Refer to Fig. S2 for examples of simula-
tions with direct binding of CI and MOR to DNA.)
Therefore, we instead focus on the model that includes
sequestration of CI into a complex with MOR before
DNA binding. An example of PR repression simulated by
this model is shown in Fig. 5 A (black curve).
The sequestration of CI into a complex with MOR intro-
duces a hysteresis effect into the system. High initial
concentrations of MOR compared with CI leads to full
initial sequestration of CI, leaving only the complex to
repress PR. In contrast, at low initial MOR concentrations,
the CI forms homodimers, leading first to repression of
the PL promoter and a further decrease in MORFIGURE 5 Model of PR repression in systems containing both CI and
MOR. (A) Simulated PR activity by the model with CI sequestration for
systems with high (black curve) or low (dashed black curve) initial concen-
trations of MOR. Solid circles represent experimental data from Fig. 2 B
rescaled according to Fig. 3. The gray curve is the unconstrained simulation
of PR activity in the absence of MOR, equivalent to the curve in Fig. 4 A.
The dashed gray curve is the simulated PR activity by the model without
CI sequestration. (B) Relation between concentration of free CI and total
CI, clearly showing the hysteresis effect. High initial concentrations of
MOR lead to CI sequestration and thus low free CI concentrations even
when total CI increases (solid black curve). In contrast, at low initial
MOR concentrations, free CI is only depleted by dimer formation, resulting
in high levels of free CI (dashed black curve). The simulation is based on
the parameters of the unconstrained simulation given in Fig. 4 D, with
DGHET ¼ 10.5 kcal/mol, DGM ¼ 6.4 kcal/mol, and [MOR]total ¼
105 M at full PL activity.
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tion between free CI and total CI concentration. Note that
this hysteresis effect is similar in nature to the characteristic
feature of bistability predicted for plots of PL activity versus
uncontrolled PR activity by Nakanishi et al. (5).
In the experimental strains, the steady state is established
from a state of fully active PL promoter and consequently
a high MOR expression level. The unweighted SSR was
thus calculated for the fully drawn branch of the PR curve
in Fig. 5 A. The best scoring parameter sets all presented
similar PR activity trajectories (SSR ~ 1580). The energy
of CI-MOR binding is 10.6 kcal/mol for the simulation
in Fig. 5 A. This corresponds to a dissociation constant of
~20 nM, implying that CI is sequestrated in the complex
at concentrations 50-fold lower than the assumed lysogenic
CI concentration. In contrast, the binding energy of the
complex to DNA is only 6.4 kcal/mol in the simulation,
indicating that this binding could be omitted from the
model. Instead, the simulations assign the observed PR
repression to CI dimer binding in both the absence and pres-
ence of MOR. However, the experimental data show
a 20-fold stronger PR repression level in the presence of
MOR than in its absence (see insets in Fig. 2, A and B).
This inconsistency between the simulations and the data
reveals the incompleteness of the biological model.DISCUSSION
Experimental data show that upon a 600-fold increase in CI
repressor, the lysogenic promoter PR is repressed 25-fold in
the absence of MOR, compared with a 500-fold repression
of PR in the presence of MOR. In the repression of PR by
CI in the absence of MOR, a stepwise manner is indicated,
with a plateau held at approximately half of the full PR
activity upon a 10-fold increase in CI concentration.
To simulate the repression profile of PR, we use a mathe-
matical model that includes pair- and triplewise cooperative
binding of CI dimers. In an unconstrained fitting between
the model and the data, the model predicts that two of the
known CI-binding sites should bind CI more weakly than
the third, and that the OR site will always be one of the
weaker sites. This is consistent with the binding-strength
determinations of Johansen et al. (6), and strengthens our
acceptance of the model. The plateau in these simulations
is realized by competition for occupation of the two weaker
sites, both supported by cooperative binding to the stronger
site. At CI concentrations just below 1 WIU, this competi-
tion would allow for some activity from PR while keeping
PL repressed. We thus speculate that the OD site not only
stabilizes the fully repressed state but also secures
a controlled replenishing of CI.
In the presence of MOR, PR is held open over a 200-fold
range of CI concentrations before being repressed. This
shows that binding of CI:MOR at DNA is not the sole action
of MOR, and that MOR evidently functions by inhibiting CIBiophysical Journal 100(2) 313–321binding at DNA. Somewhat similar mechanisms were
reported for antirepressors of other bacteriophages, including
the Tum protein of phage 186 (21), and Coi of phage P1 (22).
The two models of PR repression in the presence of both
CI and MOR considered here originate from the models pre-
sented by Nakanishi et al. (5), who verified that sequestra-
tion of CI into a CI:MOR complex could be part of the
switch mechanism. However, although the other model, in
which CI and MOR bind together directly at the DNA,
was proved to be theoretically unlikely, it could not be dis-
carded. We compared the results from simulations by the
two models with our experimental data and found that the
model that does not allow interaction between CI and
MOR before DNA binding cannot concurrently fit the two
data sets on PR activity. This allows us to conclusively
discard the model of direct binding.
The two-state behavior observed in our data, with high
and low activity of PR, respectively, does not correspond
to the known immune and antiimmune states, as high PR
activity is associated with a high level of MOR. In contrast,
TP901-1 is known to have an antiimmune state character-
ized by substantial repression of PR and full activity of PL
(7). The model of CI sequestration may fit the data but
accordingly fails to identify a classic antiimmune state.
Indeed, one can omit repression of PR by the CI:MOR
complex from the model without significantly changing
the fit. The model assigns the observed repression to CI
dimer binding in both the absence and presence of MOR.
However, our experiments revealed a 20-fold stronger
repression of PR at high CI concentrations in the presence
of MOR than in its absence. This shows that the same mech-
anism cannot account for the repression in the two situa-
tions. Previous studies showed that repression of PR by the
CI:MOR complex was needed to reproduce the known
difference in PR activity between the immune and antiim-
mune states (5).
This inconsistency between the biological model and the
data became apparent in the mathematical simulations, and
shows that a revised model of the switch mechanisms is
needed. Inspired by the RelB-RelE system of E. coli, we
propose that a large, inactive CI:MOR complex may form
at unnaturally high MOR/CI ratios (23,24). The inability
of such a large complex to repress PR could explain the
absence of the antiimmune state in our constructs, based
on the high level of MOR present in the strains when CI
is introduced. It also offers an explanation for previous find-
ings indicating that MOR in large excess inhibits the forma-
tion of plaques (7). In contrast, lower MOR/CI ratios may
lead to an active complex that represses PR.
As with phage l (25–27), the illusive nature of antiim-
mune repressors makes it difficult to determine their full
range of capabilities. However, our data should establish
a reliable model for CI repression of PL because immunity
against superinfection requires that CI alone should be
able to act in trans.
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